The effect of aspirin in transfusion-related acute lung injury in critically ill patients

Anaesthesia

Volumn 67, Issue 6, 2012, Pages 594-599

  Tuinman, P R ^a   Vlaar, A P ^a   Binnenkade, J M ^a   Juffermans, N P ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID;

ARTICLE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DRUG EFFECT; ERYTHROCYTE TRANSFUSION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; PLASMA TRANSFUSION; POST HOC ANALYSIS; THROMBOCYTE TRANSFUSION; TRANSFUSION RELATED ACUTE LUNG INJURY;

ACUTE LUNG INJURY; ADULT; AGED; APACHE; ASPIRIN; BLOOD TRANSFUSION; CASE-CONTROL STUDIES; COHORT STUDIES; CRITICAL ILLNESS; ERYTHROCYTE TRANSFUSION; FEMALE; HUMANS; INTENSIVE CARE; MALE; MIDDLE AGED; PLASMA; PLATELET AGGREGATION INHIBITORS; PLATELET TRANSFUSION; POSTOPERATIVE CARE; PREOPERATIVE CARE; RISK ASSESSMENT;

EID: 84860837380     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/j.1365-2044.2011.07054.x     Document Type: Article

References (38)

1. Rao MP, Boralessa H, Morgan C, et al., Blood component use in critically ill patients. Anaesthesia 2002; 57: 530-4.
2. Goldman M, Webert KE, Arnold DM, Freedman J, Hannon J, Blajchman MA,. Proceedings of a consensus conference: towards an understanding of TRALI. Transfusion Medicine Reviews 2005; 19: 2-31.
3. Barrett NA, Kam PC,. Transfusion-related acute lung injury: a literature review. Anaesthesia 2006; 61: 777-85.
4. Silliman CC,. The two-event model of transfusion-related acute lung injury. Critical Care Medicine 2006; 34: S124-31.
5. Gajic O, Rana R, Winters JL, et al., Transfusion-related acute lung injury in the critically ill: prospective nested case-control study. American Journal of Respiratory and Critical Care Medicine 2007; 176: 886-91.
6. Vlaar AP, Binnekade JM, Prins D, et al., Risk factors and outcome of transfusion-related acute lung injury in the critically ill: a nested case-control study. Critical Care Medicine 2010; 38: 771-8.
7. Zarbock A, Ley K,. The role of platelets in acute lung injury (ALI). Frontiers in Bioscience 2009; 14: 150-8.
8. Bozza FA, Shah AM, Weyrich AS, Zimmerman GA,. Amicus or adversary: platelets in lung biology, acute injury, and inflammation. American Journal of Respiratory and Cell and Molecular Biology 2009; 40: 123-34.
9. Heffner JE, Sahn SA, Repine JE,. The role of platelets in the adult respiratory distress syndrome. Culprits or bystanders? American Review of Respiratory Disease 1987; 135: 482-92.
10. Hidalgo A, Chang J, Jang JE, Peired AJ, Chiang EY, Frenette PS,. Heterotypic interactions enabled by polarized neutrophil microdomains mediate thromboinflammatory injury. Nature Medicine 2009; 15: 384-91.
11. Zarbock A, Singbartl K, Ley K,. Complete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregation. Journal of Clinical Investigation 2006; 116: 3211-9.
12. Looney MR, Nguyen JX, Hu Y, Van Ziffle JA, Lowell CA, Matthay MA,. Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion-related acute lung injury. Journal of Clinical Investigation 2009; 119: 3450-61.
13. Erlich JM, Talmor DS, Cartin-Ceba R, Gajic O, Kor DJ,. Pre-hospitalization anti-platelet therapy is associated with a reduced incidence of acute lung injury: a population-based cohort study. Chest 2011; 139: 289-95.
14. Kor DJ, Erlich J, Gong MN, et al., Association of prehospitalization aspirin therapy and acute lung injury: results of a multicenter international observational study of at-risk patients. Critical Care Medicine 2011; 39: 2393-400.
15. Vlaar AP, Hofstra JJ, Determann RM, et al., The incidence, risk factors, and outcome of transfusion-related acute lung injury in a cohort of cardiac surgery patients: a prospective nested case-control study. Blood 2011; 117: 4218-25.
16. Smith SC Jr, Allen J, Blair SN, et al., AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 2006; 113: 2363-72.
17. Benson AB, Austin GL, Berg M, et al., Transfusion-related acute lung injury in ICU patients admitted with gastrointestinal bleeding. Intensive Care Medicine 2010; 36: 1710-7.
18. Moss M, Guidot DM, Steinberg KP, et al., Diabetic patients have a decreased incidence of acute respiratory distress syndrome. Critical Care Medicine 2000; 28: 2187-92.
19. Moss M, Parsons PE, Steinberg KP, et al., Chronic alcohol abuse is associated with an increased incidence of acute respiratory distress syndrome and severity of multiple organ dysfunction in patients with septic shock. Critical Care Medicine 2003; 31: 869-77.
20. Iribarren C, Jacobs DR Jr, Sidney S, Gross MD, Eisner MD,. Cigarette smoking, alcohol consumption, and risk of ARDS: a 15-year cohort study in a managed care setting. Chest 2000; 117: 163-8.
21. Wallis JP, Lubenko A, Wells AW, Chapman CE,. Single hospital experience of TRALI. Transfusion 2003; 43: 1053-9.
22. Ware LB, Matthay MA,. The acute respiratory distress syndrome. New England Journal of Medicine 2000; 342: 1334-49.
23. van Hilten JA, van de Watering LM, van Bockel JH, et al., Effects of transfusion with red cells filtered to remove leucocytes: randomised controlled trial in patients undergoing major surgery. British Medical Journal 2004; 328: 1281.
24. Sihler KC, Napolitano LM,. Massive transfusion: new insights. Chest 2009; 136: 1654-67.
25. Kleinman S, Caulfield T, Chan P, et al., Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion 2004; 44: 1774-89.
26. Gajic O, Gropper MA, Hubmayr RD,. Pulmonary edema after transfusion: how to differentiate transfusion-associated circulatory overload from transfusion-related acute lung injury. Critical Care Medicine 2006; 34: S109-13.
27. Benson AB, Moss M, Silliman CC,. Transfusion-related acute lung injury (TRALI): a clinical review with emphasis on the critically ill. British Journal of Haematology 2009; 147: 431-43.
28. Silliman CC, Boshkov LK, Mehdizadehkashi Z, et al., Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood 2003; 101: 454-62.
29. Reagan-Shaw S, Nihal M, Ahmad N,. Dose translation from animal to human studies revisited. Journal of the Federation of American Societies for Experimental Biology 2008; 22: 659-61.
30. Patrignani P, Filabozzi P, Patrono C,. Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects. Journal of Clinical Investigation 1982; 69: 1366-72.
31. Patrono C, Garcia Rodriguez LA, Landolfi R, Baigent C,. Low-dose aspirin for the prevention of atherothrombosis. New England Journal of Medicine 2005; 353: 2373-83.
32. Schror K,. Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis. Seminars in Thrombosis and Hemostasis 1997; 23: 349-56.
33. Adawi A, Zhang Y, Baggs R, Finkelstein J, Phipps RP,. Disruption of the CD40-CD40 ligand system prevents an oxygen-induced respiratory distress syndrome. American Journal of Pathology 1998; 152: 651-7.
34. Fulkerson WJ, MacIntyre N, Stamler J, Crapo JD,. Pathogenesis and treatment of the adult respiratory distress syndrome. Archives of Internal Medicine 1996; 156: 29-38.
35. Fukunaga K, Kohli P, Bonnans C, Fredenburgh LE, Levy BD,. Cyclooxygenase 2 plays a pivotal role in the resolution of acute lung injury. Journal of Immunology 2005; 174: 5033-9.
36. Ben-Dor I, Kleiman NS, Lev E,. Assessment, mechanisms, and clinical implication of variability in platelet response to aspirin and clopidogrel therapy. American Journal of Cardiology 2009; 104: 227-33.
37. Mestas J, Hughes CC,. Of mice and not men: differences between mouse and human immunology. Journal of Immunology 2004; 172: 2731-8.
38. Tsakiris DA, Scudder L, Hodivala-Dilke K, Hynes RO, Coller BS,. Hemostasis in the mouse (Mus musculus): a review. Thrombosis and Haemostasis 1999; 81: 177-88.